<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01412996</url>
  </required_header>
  <id_info>
    <org_study_id>Single access chOLECYSTECTOMY</org_study_id>
    <nct_id>NCT01412996</nct_id>
  </id_info>
  <brief_title>Quality of Life Measures After Single Access Vs Conventional Laparoscopic Cholecystectomy: Prospective Randomized Study.</brief_title>
  <official_title>Single Access Laparoscopic Cholecystectomy</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Mansoura University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Mansoura University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study aimed to compare the short term outcomes between SALC and conventional
      laparoscopic cholecystectomy (CLC).
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      In a prospective study, two hundred fifty patients with symptomatic gall bladder stone were
      randomized to SALC or conventional laparoscopic cholecystectomy (CLC) (125 in each group).
      The primary endpoint of this study was to assess the total outcomes of quality of life using
      EuroQoL EQ-5D questionnaire. The secondary endpoints were postoperative pain, analgesia
      requirement and duration, operative time, perioperative complications, estimated blood loss,
      hospital stay, cosmoses outcomes and number of days required to return to normal activities.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>November 2009</start_date>
  <completion_date type="Actual">January 2012</completion_date>
  <primary_completion_date type="Actual">January 2012</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>QUALITY OF LIFE</measure>
    <time_frame>PREOPERATIVEELY, after 1 WEEK, 1 and 6 months postoperative</time_frame>
    <description>Quality of life was the primary endpoint of this study assessed by EuroQoL EQ-5D 9 questionnaire preoperatively, 1 week, 1 and 6 months after surgery. The EQ-5D is a validated questionnaire which consists of 2 pages: the EQ-5D descriptive system and EQ visual analogue scale (EQ VAS). The WQ-5D-descriptive system consists of 5 dimensions: mobility, self-care, usual activities, pain/discomfort and anxiety/depression. Each dimension has 3 levels: no problems, some problems, extreme problems.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>operative time</measure>
    <time_frame>2 hours</time_frame>
    <description>(defined as the interval between the initial skin incision and skin closure)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>postoperative pain</measure>
    <time_frame>5 days</time_frame>
    <description>using verbal analogue scale (VAS) from 0 to 10 (0 = no pain, 10 = severe pain)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>days to return to normal activity (RTNA)</measure>
    <time_frame>10 days</time_frame>
    <description>patients were contacted by phone every day until they are able to return to their normal daily works</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>COSMOSIS OUTCOMES</measure>
    <time_frame>1 AND 6 MONTHS</time_frame>
    <description>cosmetic outcomes 1 and 6 months after surgery using Patient and Observer Scar Assessment Scale (POSAS)(10), it comprises two distinct series of Visual Analogue Scale (VAS) instruments: one is self-assessed by the patient and one by an independent doctor, ranging from 1 (poor) to 10 (excellent)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>ANALGESIC REQUIRMENT</measure>
    <time_frame>POSTOPERATIVE PERIOD</time_frame>
    <description>NOMBERS OF ANALGESIC TABLETS AND NO. OF DAYS ANALGESIA NEEDED</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">250</enrollment>
  <condition>Evidence of Cholecystectomy</condition>
  <arm_group>
    <arm_group_label>single ACCESS cholecystectomy</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>single ACCESS laparoscopic cholecystectomy</description>
  </arm_group>
  <arm_group>
    <arm_group_label>traditional</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>conventional laparoscopic cholecystectomy</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>surgery</intervention_name>
    <description>single ACCESS laparoscopic cholecystectomy</description>
    <arm_group_label>single ACCESS cholecystectomy</arm_group_label>
    <other_name>SALC</other_name>
    <other_name>GROUP I</other_name>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>SURGERY</intervention_name>
    <description>CONVENTIONAL LAPAROSCOPIC CGOLECYSTECTOMY</description>
    <arm_group_label>traditional</arm_group_label>
    <other_name>CLC</other_name>
    <other_name>GROUP II</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  GALL BLADDER STONES

        Exclusion Criteria:

          -  ACUTE CHOLECYSTITIS

          -  PREVIOUS LAPAROTOMY

          -  ASA ABOVE 3
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>RAMADAN ELLITHY, MD</last_name>
    <role>Study Chair</role>
    <affiliation>Mansoura University</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Mohamed Abdellatif</name>
      <address>
        <city>Mansoura</city>
        <zip>35516</zip>
        <country>Egypt</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Egypt</country>
  </location_countries>
  <verification_date>February 2012</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>August 4, 2011</study_first_submitted>
  <study_first_submitted_qc>August 8, 2011</study_first_submitted_qc>
  <study_first_posted type="Estimate">August 9, 2011</study_first_posted>
  <last_update_submitted>February 24, 2012</last_update_submitted>
  <last_update_submitted_qc>February 24, 2012</last_update_submitted_qc>
  <last_update_posted type="Estimate">February 27, 2012</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Mansoura University</investigator_affiliation>
    <investigator_full_name>MOHAMED ABDELLATIF</investigator_full_name>
    <investigator_title>ASS. PROF.</investigator_title>
  </responsible_party>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

